Precision BioSciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $10,838 | $34,204 | $13 | $18 |
Gross Profit | 10,838 | 33,526 | 13 | -678 |
EBITDA | -8,435 | 20,274 | -20,736 | -22,466 |
EBIT | -9,075 | 19,596 | -21,410 | -23,162 |
Net Income | -18,441 | 19,248 | -21,772 | -23,520 |
Net Change In Cash | 10,838 | 34,204 | 13 | 18 |
Free Cash Flow | -11,955 | -11,284 | -15,270 | -20,273 |
Cash | 99,370 | 110,823 | 44,870 | 62,242 |
Basic Shares | 12,826 | 12,826 | 11,818 | 11,046 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $34,264 | $68,696 | $48,727 | $25,098 |
Gross Profit | 31,511 | 68,696 | 48,727 | 25,098 |
EBITDA | -49,395 | 13,526 | -32,042 | -62,794 |
EBIT | -52,148 | 8,949 | -40,297 | -71,798 |
Net Income | -46,609 | 7,167 | -61,319 | -111,637 |
Net Change In Cash | 34,264 | 68,696 | 48,727 | 25,098 |
Cost of Revenue | 45,913 | |||
Free Cash Flow | -65,928 | -58,695 | -86,392 | -49,072 |
Cash | 110,823 | 85,899 | 116,678 | 189,576 |
Basic Shares | 12,826 | 6,883 | 3,841 | 2,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.75 |
2025-12-31 | $1.00 |
2025-09-30 | -$1.84 |
2025-06-30 | -$2.13 |